Literature DB >> 18801858

Epidemiology of diabetes and diabetes-related complications.

Anjali D Deshpande1, Marcie Harris-Hayes, Mario Schootman.   

Abstract

UNLABELLED: In 2005, it was estimated that more than 20 million people in the United States had diabetes. Approximately 30% of these people had undiagnosed cases. Increased risk for diabetes is primarily associated with age, ethnicity, family history of diabetes, smoking, obesity, and physical inactivity. Diabetes-related complications--including cardiovascular disease, kidney disease, neuropathy, blindness, and lower-extremity amputation--are a significant cause of increased morbidity and mortality among people with diabetes, and result in a heavy economic burden on the US health care system. With advances in treatment for diabetes and its associated complications, people with diabetes are living longer with their condition. This longer life span will contribute to further increases in the morbidity associated with diabetes, primarily in elderly people and in minority racial or ethnic groups. In 2050, the number of people in the United States with diagnosed diabetes is estimated to grow to 48.3 million.
RESULTS: from randomized controlled trials provide evidence that intensive lifestyle interventions can prevent or delay the onset of diabetes in high-risk individuals. In addition, adequate and sustained control of blood sugar levels, blood pressure, and blood lipid levels can prevent or delay the onset of diabetes-related complications in people with diabetes. Effective interventions, at both the individual and population levels, are desperately needed to slow the diabetes epidemic and reduce diabetes-related complications in the United States. This report describes the current diabetes epidemic and the health and economic impact of diabetes complications on individuals and on the health care system. The report also provides suggestions by which the epidemic can be curbed.

Entities:  

Mesh:

Year:  2008        PMID: 18801858      PMCID: PMC3870323          DOI: 10.2522/ptj.20080020

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  73 in total

Review 1.  The diabetic foot: the scope of the problem.

Authors:  A J Boulton; L Vileikyte
Journal:  J Fam Pract       Date:  2000-11       Impact factor: 0.493

2.  Health outcomes among Hispanic subgroups: data from the National Health Interview Survey, 1992-95.

Authors:  A Hajat; J B Lucas; R Kington
Journal:  Adv Data       Date:  2000-02-25

3.  Delineating the relationship between stress, depressive symptoms, and glucose intolerance.

Authors:  A Grandinetti; J K Kaholokula; H K Chang
Journal:  Diabetes Care       Date:  2000-09       Impact factor: 19.112

4.  Economic realities associated with diabetes care: opportunities to expand delivery of physical therapist services to a vulnerable population.

Authors:  Rhea Cohn
Journal:  Phys Ther       Date:  2008-09-18

Review 5.  Diabetic neuropathies.

Authors:  A I Vinik; T S Park; K B Stansberry; G L Pittenger
Journal:  Diabetologia       Date:  2000-08       Impact factor: 10.122

6.  Surveillance of demographic characteristics and health behaviors among adult cancer survivors--Behavioral Risk Factor Surveillance System, United States, 2009.

Authors:  J Michael Underwood; Julie S Townsend; Sherri L Stewart; Natasha Buchannan; Donatus U Ekwueme; Nikki A Hawkins; Jun Li; Brandy Peaker; Lori A Pollack; Thomas B Richards; Sun Hee Rim; Elizabeth A Rohan; Susan A Sabatino; Judith L Smith; Eric Tai; George-Ann Townsend; Arica White; Temeika L Fairley
Journal:  MMWR Surveill Summ       Date:  2012-01-20

7.  Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy.

Authors:  Sean D Candrilli; Keith L Davis; Hong J Kan; Melanie A Lucero; Matthew D Rousculp
Journal:  J Diabetes Complications       Date:  2007 Sep-Oct       Impact factor: 2.852

8.  The direct medical cost of type 2 diabetes.

Authors:  Michael Brandle; Honghong Zhou; Barbara R K Smith; Deanna Marriott; Ray Burke; Bahman P Tabaei; Morton B Brown; William H Herman
Journal:  Diabetes Care       Date:  2003-08       Impact factor: 19.112

9.  The effect of adverse housing and neighborhood conditions on the development of diabetes mellitus among middle-aged African Americans.

Authors:  Mario Schootman; Elena M Andresen; Fredric D Wolinsky; Theodore K Malmstrom; J Philip Miller; Yan Yan; Douglas K Miller
Journal:  Am J Epidemiol       Date:  2007-07-11       Impact factor: 4.897

10.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11
View more
  322 in total

Review 1.  [Diabetic maculopathy and retinopathy. Functional and sociomedical significance].

Authors:  J G Garweg; A Wenzel
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy.

Authors:  Laura Galli; Stefania Salpietro; Gabriele Pellicciotta; Alberto Galliani; Piermarco Piatti; Hamid Hasson; Monica Guffanti; Nicola Gianotti; Alba Bigoloni; Adriano Lazzarin; Antonella Castagna
Journal:  Eur J Epidemiol       Date:  2012-06-22       Impact factor: 8.082

Review 3.  A meta-analysis of short-term outcomes of patients with type 2 diabetes mellitus and BMI ≤ 35 kg/m2 undergoing Roux-en-Y gastric bypass.

Authors:  Wen-Sheng Rao; Cheng-Xiang Shan; Wei Zhang; Dao-Zhen Jiang; Ming Qiu
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

4.  Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium.

Authors:  Yu Chen; Fen Wu; Eiko Saito; Yingsong Lin; Minkyo Song; Hung N Luu; Prakash C Gupta; Norie Sawada; Akiko Tamakoshi; Xiao-Ou Shu; Woon-Puay Koh; Yong-Bing Xiang; Yasutake Tomata; Kemmyo Sugiyama; Sue K Park; Keitaro Matsuo; Chisato Nagata; Yumi Sugawara; You-Lin Qiao; San-Lin You; Renwei Wang; Myung-Hee Shin; Wen-Harn Pan; Mangesh S Pednekar; Shoichiro Tsugane; Hui Cai; Jian-Min Yuan; Yu-Tang Gao; Ichiro Tsuji; Seiki Kanemura; Hidemi Ito; Keiko Wada; Yoon-Ok Ahn; Keun-Young Yoo; Habibul Ahsan; Kee Seng Chia; Paolo Boffetta; Wei Zheng; Manami Inoue; Daehee Kang; John D Potter
Journal:  Diabetologia       Date:  2017-03-07       Impact factor: 10.122

5.  Do diabetes-specialty clinics differ in management approach and outcome? A cross-sectional assessment of ambulatory type 2 diabetes patients in two teaching hospitals in Nigeria.

Authors:  Rasaq Adisa; Titilayo O Fakeye
Journal:  Ghana Med J       Date:  2016-06

6.  Temporal trends in the use of antidiabetic medicines: a nationwide 9-year study in older people living in New Zealand.

Authors:  Prasad S Nishtala; Mohammed Saji Salahudeen
Journal:  Ther Adv Drug Saf       Date:  2016-07-21

7.  Didymin prevents hyperglycemia-induced human umbilical endothelial cells dysfunction and death.

Authors:  Kirtikar Shukla; Himangshu Sonowal; Ashish Saxena; Kota V Ramana
Journal:  Biochem Pharmacol       Date:  2018-03-14       Impact factor: 5.858

8.  Diabetes burden and diabetes distress: the buffering effect of social support.

Authors:  Rachel N Baek; Molly L Tanenbaum; Jeffrey S Gonzalez
Journal:  Ann Behav Med       Date:  2014-10

Review 9.  Hyperglycemia and vascular metabolic memory: truth or fiction?

Authors:  Cristina Bianchi; Roberto Miccoli; Stefano Del Prato
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

10.  High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes.

Authors:  J Frank Wharam; Christine Y Lu; Fang Zhang; Matthew Callahan; Xin Xu; Jamie Wallace; Stephen Soumerai; Dennis Ross-Degnan; Joseph P Newhouse
Journal:  Ann Intern Med       Date:  2018-11-20       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.